Dynavax Technologies
portfoliocompanies
company snapshot

Dynavax Technologies discovers and develops products to prevent and treat infectious and inflammatory diseases. Its clinical-stage product candidates include HEPLISAV ™ Hepatitis B Vaccine, Universal Flu Vaccine , TLR Inhibitor for Lupus and Hepatitis B Therapy. The company partners with AstraZeneca, GlaxoSmithKline and other pharmaceutical companies.